Taiwan · Delayed Price · Currency is TWD TTY Biopharm Company Statistics
Total Valuation
TPEX:4105 has a market cap or net worth of TWD 18.75 billion. The enterprise value is 17.27 billion.
| Market Cap | 18.75B |
| Enterprise Value | 17.27B |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Mar 26, 2026 |
Share Statistics
TPEX:4105 has 248.65 million shares outstanding. The number of shares has increased by 5.24% in one year.
| Current Share Class | 248.65M |
| Shares Outstanding | 248.65M |
| Shares Change (YoY) | +5.24% |
| Shares Change (QoQ) | +77.28% |
| Owned by Insiders (%) | 10.52% |
| Owned by Institutions (%) | 9.33% |
| Float | 198.56M |
Valuation Ratios
The trailing PE ratio is 12.26.
| PE Ratio | 12.26 |
| Forward PE | n/a |
| PS Ratio | 2.88 |
| PB Ratio | 2.53 |
| P/TBV Ratio | 3.14 |
| P/FCF Ratio | 9.84 |
| P/OCF Ratio | 9.29 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.02, with an EV/FCF ratio of 9.06.
| EV / Earnings | 10.72 |
| EV / Sales | 2.65 |
| EV / EBITDA | 8.02 |
| EV / EBIT | 8.81 |
| EV / FCF | 9.06 |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.07.
| Current Ratio | 1.71 |
| Quick Ratio | 1.16 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.26 |
| Debt / FCF | 0.27 |
| Interest Coverage | 50.29 |
Financial Efficiency
Return on equity (ROE) is 23.94% and return on invested capital (ROIC) is 24.53%.
| Return on Equity (ROE) | 23.94% |
| Return on Assets (ROA) | 9.83% |
| Return on Invested Capital (ROIC) | 24.53% |
| Return on Capital Employed (ROCE) | 22.12% |
| Weighted Average Cost of Capital (WACC) | 5.19% |
| Revenue Per Employee | 19.05M |
| Profits Per Employee | 4.71M |
| Employee Count | 342 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.12 |
Taxes
In the past 12 months, TPEX:4105 has paid 473.42 million in taxes.
| Income Tax | 473.42M |
| Effective Tax Rate | 21.68% |
Stock Price Statistics
The stock price has decreased by -0.79% in the last 52 weeks. The beta is 0.17, so TPEX:4105's price volatility has been lower than the market average.
| Beta (5Y) | 0.17 |
| 52-Week Price Change | -0.79% |
| 50-Day Moving Average | 77.25 |
| 200-Day Moving Average | 79.13 |
| Relative Strength Index (RSI) | 54.16 |
| Average Volume (20 Days) | 878,894 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4105 had revenue of TWD 6.51 billion and earned 1.61 billion in profits. Earnings per share was 6.15.
| Revenue | 6.51B |
| Gross Profit | 3.75B |
| Operating Income | 1.78B |
| Pretax Income | 2.18B |
| Net Income | 1.61B |
| EBITDA | 1.98B |
| EBIT | 1.78B |
| Earnings Per Share (EPS) | 6.15 |
Balance Sheet
The company has 2.82 billion in cash and 515.14 million in debt, with a net cash position of 2.31 billion or 9.27 per share.
| Cash & Cash Equivalents | 2.82B |
| Total Debt | 515.14M |
| Net Cash | 2.31B |
| Net Cash Per Share | 9.27 |
| Equity (Book Value) | 7.40B |
| Book Value Per Share | 14.82 |
| Working Capital | 2.57B |
Cash Flow
In the last 12 months, operating cash flow was 2.02 billion and capital expenditures -112.98 million, giving a free cash flow of 1.91 billion.
| Operating Cash Flow | 2.02B |
| Capital Expenditures | -112.98M |
| Depreciation & Amortization | 195.24M |
| Net Borrowing | -508.93M |
| Free Cash Flow | 1.91B |
| FCF Per Share | 7.67 |
Margins
Gross margin is 57.54%, with operating and profit margins of 27.34% and 24.73%.
| Gross Margin | 57.54% |
| Operating Margin | 27.34% |
| Pretax Margin | 33.51% |
| Profit Margin | 24.73% |
| EBITDA Margin | 30.34% |
| EBIT Margin | 27.34% |
| FCF Margin | 29.26% |
Dividends & Yields
This stock pays an annual dividend of 4.50, which amounts to a dividend yield of 5.97%.
| Dividend Per Share | 4.50 |
| Dividend Yield | 5.97% |
| Dividend Growth (YoY) | 7.14% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 64.82% |
| Buyback Yield | -5.24% |
| Shareholder Yield | 0.73% |
| Earnings Yield | 8.59% |
| FCF Yield | 10.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.
| Last Split Date | Aug 13, 2014 |
| Split Type | Forward |
| Split Ratio | 1.067 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |